Journal Article Summary
The article investigates the relationship between oral contraceptive pill (OCP) use, iron stores, and vascular endothelial function in healthy women. This topic is important because increased iron stores can elevate cardiovascular risk, particularly in post-menopausal women. While OCPs are known to reduce menstrual blood loss and subsequently increase iron levels, the connection between OCP use, iron levels, and cardiovascular health in pre-menopausal women has not been thoroughly explored.
The study involved 23 healthy women aged 21 to 35 who had been using OCPs for at least three months. Researchers measured the type and duration of OCP use, iron stores, and vascular function through flow-mediated dilation (FMD) in the brachial artery. The results showed that women using OCPs containing drospirenone had significantly better FMD compared to those using estrane/gonane-containing OCPs, suggesting a more favorable cardiovascular risk profile. Interestingly, the study did not find a direct link between the duration of OCP use and iron stores, which was contrary to the researchers' initial hypothesis.
Limitations of the study include the small sample size and the lack of a control group of non-OCP users, which may affect the reliability of the findings. Additionally, the study did not account for potential confounding factors such as dietary iron intake or unmeasured blood loss. Patients should discuss these findings with their healthcare providers, especially regarding the choice of OCPs and their potential impact on cardiovascular health and iron metabolism. Further research is needed to understand the long-term effects of different OCP formulations on cardiovascular safety and iron levels.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Friedman Julie, Cremer Miriam, Jelani Qurat ul-ain, Huang Xi, Jian Jinlong, Shah Sooraj, Katz Stuart D.. Oral contraceptive use, iron stores, and vascular endothelial function in healthy women. Contraception 2011. DOI: 10.1016/j.contraception.2011.01.012. PMID: 21843695. PMCID: PMC3285555.
Featured Pill Pals Product
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) --- Perrigo --- Over The Counter
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) — Perrigo — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
